Systemic Lupus Erythematosus (SLE) Latest Advances

Find the Latest Research About Systemic Lupus Erythematosus (SLE)

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82694 publications

Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies.

Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 24, 2026

Serum RIPK3/MLKL as exploratory biomarker candidates for systemic lupus erythematosus.

Serum RIPK3/MLKL as exploratory biomarker candidates for systemic lupus erythematosus.

Journal: Lupus
Published: June 24, 2026

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with a primary focus on rituximab and belimumab.

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with a primary focus on rituximab and belimumab.

Journal: Expert opinion on biological therapy
Published: June 23, 2026

Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis.

Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis.

Journal: Lupus
Published: June 23, 2026

Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndrome.

Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndrome.

Journal: Lupus
Published: June 23, 2026

The SLC15A4-LAMTOR1 interaction licenses endolysosomal TLR-mediated mTOR signaling and inflammatory cytokine production.

The SLC15A4-LAMTOR1 interaction licenses endolysosomal TLR-mediated mTOR signaling and inflammatory cytokine production.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

New approaches to the management of cutaneous lupus.

New approaches to the management of cutaneous lupus.

Journal: Current opinion in rheumatology
Published: June 19, 2026

Multi-omics profiling characterizes the primary cilium-related molecular regulatory landscape in systemic lupus erythematosus.

Multi-omics profiling characterizes the primary cilium-related molecular regulatory landscape in systemic lupus erythematosus.

Journal: The Analyst
Published: June 18, 2026

Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review.

Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review.

Journal: Lupus
Published: June 16, 2026

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Journal: Circulation research
Published: June 16, 2026

Cardiovascular system involvement in childhood-onset systemic lupus erythematosus mechanisms and clinical practice

Cardiovascular system involvement in childhood-onset systemic lupus erythematosus mechanisms and clinical practice

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: June 16, 2026

Efficacy and safety of fourth-generation CAR-T cells targeting CD19 and BCMA with anti-IL-6 antibody secretion in refractory systemic lupus erythematosus

Efficacy and safety of fourth-generation CAR-T cells targeting CD19 and BCMA with anti-IL-6 antibody secretion in refractory systemic lupus erythematosus

Journal: Zhonghua yi xue za zhi
Published: June 15, 2026
Showing 1-12 of 82,694

Last Updated: 06/30/2026